Most importantly, BTZ led to DNA damage–associated enhancement of immunogenicity, as indicated by the potentiated expression of HMGB1 and HSP90 in B-Myb–defective colorectal cancer, further driving M1 polarization of macrophages. The gene discussed is MYBL2; the disease is colorectal cancer.